These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1094226)

  • 1. [Experience with fractionate massive-dose Ifosfamid therapy of generalized malignant tumors].
    Hoefer-Janker H; Scheef W; Günther U; Hüls W
    Med Welt; 1975 May; 26(20):972-9. PubMed ID: 1094226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with the cytostatic drug ifosfamide].
    Ritter S; Schröder HJ
    Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
    [No Abstract]   [Full Text] [Related]  

  • 3. Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.
    Brühl P; Günther U; Hoefer-Janker H; Hüls W; Scheef W; Vahlensieck W
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):29-39. PubMed ID: 789266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ifosfamide in the treatment of solid tumors and their metastases].
    Wicart L
    Nouv Presse Med; 1976 Apr; 5(15):996-8. PubMed ID: 778786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
    Hoefer H; Scheef W; Titscher R; Kokron O
    Osterr Z Onkol; 1974; (1):3-7. PubMed ID: 4619650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of ifosfamide in one-agent chemotherapy of malignant testicular tumors].
    Madej G; Porwit-Ksiazek A; Siedlecki P; Zborzil J
    Pol Tyg Lek; 1982 Jul; 37(24-25):717-9. PubMed ID: 6294642
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
    Berdel WE; Fink U; Emmerich B; Maubach PA; Busch U; Remy W; Rastetter J
    Dtsch Med Wochenschr; 1982 Jan; 107(1):26-8. PubMed ID: 7198963
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
    Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
    Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of ifosfamide in children with malignant solid tumors.
    Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA
    Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of Iphosphamide in phracological treatment of neoplasms].
    Madej G; Zelechowska JA
    Pol Tyg Lek; 1975 Jun; 30(22):955-7. PubMed ID: 1135071
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
    Retsas S
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drug found active against lung cancers.
    Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.